CHO Cell-Produced Truncated Bovine Ephemeral Fever Virus Glycoprotein as a Promising Subunit Vaccine Candidate for Cattle
Vaccines · 15.03.2026 · 14 (3) · 265
DOI: 10.3390/vaccines14030265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 15.03.2026. Verfasst von Huan-Yu Hsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: International Degree Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Neipu, Ping…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Bovine ephemeral fever (BEF) is a significant disease affecting the cattle industry. The current control strategy for BEF in the field primarily relies on inactivated vaccines. However, some individuals have experienced hypersensitive reactions to these vaccines, prompting the exploration of subunit vaccines as a potential alternative for BEF prevention. Glycoprotein (G protein)-based subunit vaccines derived from virions have successfully induced neutralizing antibodies in cattle for over a decade. Nevertheless, the lack of recent studies evaluating their efficacy using recombinant proteins has raised concerns regarding the development of BEF subunit vaccines for practical field application. Therefore, the objective of this study was to evaluate the antigenicity of a novel truncated G protein produced in mammalian cells as a candidate subunit vaccine for BEF in cattle.
Methods
In this study, the G protein with full ectodomain and a version truncated at the C-terminal domain were successfully generated using the ExpiCHO™ expression system. Vaccine efficacy was evaluated weekly by measuring neutralizing antibody titers and cytokine mRNA expression levels following vaccination.
Results
Results show that the recombinant protein s510, derived from the G protein of BEF, can stimulate cattle to produce an average 35-fold increase in neutralizing antibodies after three doses of vaccination. The significant upregulation of IFN-γ mRNA supports the effectiveness of the s510-based subunit vaccine and indicates the activation of a cytotoxic immune response in cattle following vaccination.
Conclusions
In conclusion, the results indicate that the recombinant protein s510 is a promising antigen for future BEF subunit vaccine development in this study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Degree Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Neipu, Pingtung 91201, Taiwan.
- Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Neipu, Pingtung 91201, Taiwan.
- Research Center for Animal Biologics, College of Veterinary Medicine, National Pingtung University of Science and Technology, Neipu, Pingtung 91201, Taiwan.
Zitieren
APA
Hsu, H. Y., Yeh, S. J., Chen, C. C., & Ke, G. M. (2026). CHO Cell-Produced Truncated Bovine Ephemeral Fever Virus Glycoprotein as a Promising Subunit Vaccine Candidate for Cattle. Vaccines, 14(3), 265. https://doi.org/10.3390/vaccines14030265
Vancouver
Hsu HY, Yeh SJ, Chen CC, Ke GM. CHO Cell-Produced Truncated Bovine Ephemeral Fever Virus Glycoprotein as a Promising Subunit Vaccine Candidate for Cattle. Vaccines. 2026;14(3):265. doi:10.3390/vaccines14030265
BibTeX
@article{Hsu2026,
author = {Hsu, Huan-Yu and Yeh, Shu-Ju and Chen, Chi-Chih and Ke, Guan-Ming},
title = {CHO Cell-Produced Truncated Bovine Ephemeral Fever Virus Glycoprotein as a Promising Subunit Vaccine Candidate for Cattle},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {3},
pages = {265},
doi = {10.3390/vaccines14030265}
}
EUVIMED